Journal of Biological Chemistry · 2020 · 69 citations · 22 references
MedicineCancer BiologyOncologyCancer GeneticsMolecular OncologyTranscriptional RegulationCancer Cell SignalingCancer ProgressionOncogenic ProliferationOncogenic Signaling PathwaysSignal Transduction In CancerTumor Suppressor GenesCancer Cell Proliferation InhibitionCancer Signaling PathwaysHippo SignalingHippo Signaling PathwayMalignant Breast TumorsTumor Cell ProliferationYap And Taz SignalingYap Signaling
Vestigial-like 3 (VGLL3) is a member of the VGLL family, whose members serve as cofactors for TEA domain-containing transcription factors (TEADs). TEADs promote tissue and tumor development together with the cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Although VGLL3 is involved in tumor cell proliferation, its relationship with TEADs and YAP/TAZ remains largely unknown. To close this research gap, here we established tumor cells stably expressing VGLL3 and found that they exhibit enhanced proliferation. Notably, YAP and TAZ were inactivated in the VGLL3-expressing cells, coinciding with activation of the Hippo pathway, which suppresses YAP/TAZ activities. VGLL3 in combination with TEADs promoted expression of the Hippo pathway components large tumor suppressor kinase (LATS2) and angiomotin-like 2 (AMOTL2). VGLL3 was highly expressed in malignant breast tumor cells and osteosarcoma cells, and VGLL3 knockdown increased nuclear localization of YAP and TAZ. Knockdown of LATS2 or AMOTL2, as well as VGLL3 knockdown, repressed proliferation of breast tumor cells. Together, these results suggest that VGLL3 together with TEADs promotes cell proliferation by activating the Hippo pathway through LATS2 and AMOTL2, leading to YAP/TAZ inactivation.
22
Role of YAP/TAZ in mechanotransduction
Sirio Dupont, Leonardo Morsut, Mariaceleste Aragona et al. · Nature · 2011 · 5.9K citations · Full text
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao, Xin Ye, Jindan Yu et al. · Genes & Development · 2008 · 2.5K citations · Full text
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Yawei Hao, Alex Chun, Kevin J. Cheung et al. · Journal of Biological Chemistry · 2007 · 812 citations · Full text
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao, Li Li, Q. Richard Lu et al. · Genes & Development · 2011 · 667 citations · Full text
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao, Huizhen Wang, Zhubing Shi et al. · Cancer Cell · 2014 · 601 citations · Full text